Central Lipid Metabolism Pathways

Lipid Metabolism Introduction Lipid metabolism encompasses the biosynthesis and degradation of fatty acids, triglycerides, and cholesterol. These processes are fundamental to energy storage, cell membrane structure, and signaling. Understanding lipid metabolism requires mastering two complementary processes: lipogenesis (building lipids from smaller precursors) and β-oxidation (breaking down fatty acids for energy). Fatty Acid Biosynthesis (Lipogenesis) Overview of the Process Fatty acid biosynthesis occurs primarily in the cytoplasm and converts excess dietary carbohydrates into saturated fatty acids. The key enzyme is fatty acid synthase (FAS), which builds fatty acids by repeatedly adding two-carbon units derived from acetyl-CoA. The Role of Acetyl-CoA Carboxylase (the Committed Step) The first committed step in fatty acid synthesis is catalyzed by acetyl-CoA carboxylase, which converts acetyl-CoA to malonyl-CoA: $$\text{Acetyl-CoA} + \text{CO}2 + \text{ATP} \rightarrow \text{Malonyl-CoA} + \text{ADP} + \text{Pi}$$ This step is critical because it commits the acetyl-CoA to lipid synthesis rather than other pathways (like the citric acid cycle). Malonyl-CoA serves two purposes: it provides the activated two-carbon unit for fatty acid elongation, and its presence inhibits fatty acid degradation (discussed later). The Fatty Acid Synthase Cycle Once malonyl-CoA is formed, fatty acid synthase catalyzes the stepwise addition of two-carbon units through a repeated four-step cycle: Condensation: The two-carbon malonyl group (from malonyl-CoA) condenses with the growing fatty acid chain, releasing CO₂ First Reduction: A ketone intermediate is reduced to a secondary alcohol using NADPH Dehydration: Water is removed, creating a double bond Second Reduction: The double bond is reduced using another NADPH, yielding a saturated chain extended by two carbons This cycle repeats until the fatty acid reaches approximately 16 carbons (palmitate), at which point the enzyme releases the product. Importantly, two NADPH molecules are consumed per two-carbon addition, making this process highly dependent on the availability of reducing power. Regulation by Allosteric Control The committed enzyme, acetyl-CoA carboxylase, is tightly regulated by allosteric mechanisms: Citrate (a sign of energy abundance) activates the enzyme, promoting fatty acid synthesis when glucose is plentiful Palmitoyl-CoA (the product of fatty acid synthesis itself) inhibits the enzyme through negative feedback, preventing overproduction This elegant feedback loop prevents wasteful synthesis when fatty acid levels are already high. Production of Unsaturated Fatty Acids Desaturation in Animals While fatty acid synthase produces only saturated fatty acids (primarily palmitate, a 16-carbon fatty acid), most tissues require unsaturated fatty acids for optimal membrane function. Mammals introduce double bonds into saturated fatty acids through enzymes called desaturases. A key example is stearoyl-CoA desaturase-1, which converts stearic acid (C₁₈ saturated) to oleic acid (C₁₈ with one double bond): $$\text{Stearoyl-CoA} + \text{O}2 + 2\text{NADH} \rightarrow \text{Oleoyl-CoA} + 2\text{NAD}^+ + 2\text{H}2\text{O}$$ Importantly, mammals can only introduce double bonds up to carbon 9 (counting from the carboxyl end). This limitation is clinically significant. Essential Fatty Acids Linoleic acid (C₁₈ with double bonds at positions 9 and 12) and α-linolenic acid (C₁₈ with double bonds at positions 9, 12, and 15) cannot be synthesized by mammals because they lack the enzymes to introduce double bonds beyond position 9. These essential fatty acids must be obtained from dietary sources (plants and seeds). Their importance cannot be overstated—they serve as precursors for signaling molecules and are required for proper immune and cardiovascular function. Triglyceride Synthesis Location and Pathway Triglycerides (also called triacylglycerols) are synthesized in the endoplasmic reticulum through a stepwise esterification process: First esterification: A fatty-acyl-CoA group is esterified to glycerol-3-phosphate at the sn-1 position, forming lysophosphatidic acid Second esterification: A second fatty-acyl-CoA is added at the sn-2 position, forming diacylglycerol phosphate (phosphatidic acid) Phosphate removal: The phosphate is removed by phosphatidic acid phosphatase Third esterification: A third fatty-acyl-CoA is added to form the completed triglyceride The three fatty acids in a triglyceride need not be identical; different combinations produce triglycerides with distinct physical properties (melting points, solubility), which explains why some oils are liquid at room temperature while others are solid (fats). Isoprenoid Synthesis: Two Pathways Why Two Pathways? Isoprenoids are a diverse class of biomolecules built from five-carbon isoprene units. They include cholesterol, carotenoids, quinones, and lipid-like prenylation groups that modify proteins. Two distinct pathways have evolved to generate the foundational isoprene building blocks: The Mevalonate Pathway (Animals and Archaea) The mevalonate pathway is the primary route for isoprenoid synthesis in animals and archaea. It proceeds as follows: Formation of HMG-CoA: Two acetyl-CoA molecules condense (via acetyl-CoA acetyltransferase and HMG-CoA synthase) to form 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) Rate-limiting reduction: HMG-CoA reductase catalyzes the committed step, reducing HMG-CoA to mevalonate using NADPH. This is the rate-limiting step of the entire pathway and a major control point. Phosphorylation and decarboxylation: Mevalonate is phosphorylated twice (consuming ATP) and then decarboxylated to form isopentenyl diphosphate (IPP) and its isomer dimethylallyl diphosphate (DMAPP) Condensation into polyisoprenoids: Successive condensation reactions link IPP units together in a head-to-tail fashion, generating geranyl diphosphate (10 carbons), farnesyl diphosphate (15 carbons), and finally squalene (30 carbons from six isoprene units) The DXP Pathway (Bacteria and Plants) Most bacteria and plant chloroplasts use an alternative 1-deoxy-D-xylulose-5-phosphate (DXP) pathway, which begins with different starting materials: Condensation of pyruvate and glyceraldehyde-3-phosphate: These molecules condense to form DXP, catalyzed by DXP synthase Rearrangement and reduction: Through a series of rearrangements and reductions, the pathway yields IPP and DMAPP Same downstream reactions: From this point onward, the DXP pathway converges with the mevalonate pathway Key distinction: The DXP pathway uses glycolytic intermediates and is therefore more economical in bacteria, whereas the mevalonate pathway processes acetyl-CoA directly, which is more abundant in animals. Polyisoprenoid Synthesis Once IPP and DMAPP are available, prenyltransferases catalyze sequential head-to-tail condensations: $$\text{DMAPP} + n \text{(IPP)} \rightarrow \text{Polyprenyl diphosphate}$$ The resulting polyisoprenoids consist of long chains of linked isoprene units and serve diverse roles: membrane lipids (like dolichol), electron carriers (ubiquinone), and precursors for sterol synthesis. Sterol Biosynthesis From Squalene to Cholesterol After squalene is synthesized (from six isoprene units), it undergoes a dramatic transformation into cholesterol through approximately 19 enzymatic steps: Cyclization to Lanosterol: Squalene is cyclized by squalene monooxygenase to form lanosterol, a steroid with four fused rings and a side chain Demethylation and isomerization: Lanosterol undergoes removal of three methyl groups and repositioning of a double bond, yielding cholesterol Cholesterol is the primary sterol in animal cell membranes, where it modulates membrane fluidity and serves as a precursor for steroid hormones and bile acids. Ergosterol in Fungi Fungi synthesize ergosterol instead of cholesterol through a nearly identical pathway. The key structural difference is the presence of an additional double bond in ergosterol's side chain. This distinction is clinically important because: Antifungal agents (azoles like fluconazole) inhibit the enzymatic conversion of lanosterol to ergosterol Without ergosterol, fungal cell membranes become compromised, and the cells die This mechanism makes azoles highly selective—mammalian cells lack these specific enzymes and are less affected Regulation of Isoprenoid and Sterol Synthesis The Critical Control Point The synthesis of isoprenoids is primarily controlled at the level of HMG-CoA reductase in the mevalonate pathway. This enzyme is regulated by multiple mechanisms: Transcriptional regulation: Low cholesterol levels increase expression of HMG-CoA reductase Post-translational regulation: High cholesterol levels promote phosphorylation and inactivation of the enzyme Protein degradation: Excess cholesterol triggers ubiquitination and proteasomal degradation of the enzyme Clinical Significance: Statins Statin drugs (such as atorvastatin and simvastatin) are competitive inhibitors of HMG-CoA reductase. By blocking this rate-limiting step, statins reduce cholesterol synthesis by approximately 30–50%, with profound clinical effects: Decreased plasma LDL cholesterol (the "bad" form) Reduced risk of cardiovascular disease and stroke Potential anti-inflammatory and plaque-stabilizing effects beyond cholesterol lowering The dramatic clinical success of statins underscores the importance of the mevalonate pathway in human health. Fatty Acid Degradation (β-Oxidation) Overview While fatty acid synthesis builds lipids from two-carbon units, β-oxidation breaks down fatty acids by removing two carbons at a time in the form of acetyl-CoA. This process occurs primarily in mitochondria (for most fatty acids) and in peroxisomes (for very long-chain fatty acids). β-Oxidation is the major source of energy from stored fat. The β-Oxidation Cycle Each cycle of β-oxidation removes a two-carbon fragment and involves four enzymatic steps: Dehydrogenation (Oxidation): A fatty-acyl-CoA dehydrogenase introduces a double bond between the α and β carbons (hence the name "β-oxidation"), producing a trans double bond. This step generates FADH₂ for the electron transport chain. Hydration: Enoyl-CoA hydratase adds water across the double bond, forming a hydroxy-acyl-CoA intermediate Second Dehydrogenation (Oxidation): Another dehydrogenase oxidizes the hydroxyl group to a ketone, generating another NADH Thiolysis (Cleavage): β-Ketothiolase cleaves the molecule between the α and β carbons using a CoA molecule, releasing one acetyl-CoA and regenerating a fatty-acyl-CoA that is two carbons shorter This shortened fatty-acyl-CoA re-enters the cycle, and the process repeats until the entire fatty acid is converted to acetyl-CoA. Energy Yield The complete oxidation of a fatty acid yields substantial ATP. For example, palmitate (a 16-carbon saturated fatty acid): Generates 8 acetyl-CoA molecules (from 8 cycles of β-oxidation) Produces 7 NADH and 7 FADH₂ from the oxidative steps Each acetyl-CoA yields approximately 10 ATP through the citric acid cycle Each NADH yields approximately 2.5 ATP, and each FADH₂ yields approximately 1.5 ATP $$\text{Palmitate} \rightarrow 8 \text{ Acetyl-CoA} + 7 \text{ NADH} + 7 \text{ FADH}2$$ $$\text{Total ATP} \approx (8 \times 10) + (7 \times 2.5) + (7 \times 1.5) = 80 + 17.5 + 10.5 = 108 \text{ ATP}$$ (In practice, values are often cited as 106 ATP to account for ATP used in initial fatty acid activation and the actual P/O ratios in the electron transport chain.) Handling Unsaturated Fatty Acids Unsaturated fatty acids require two auxiliary enzymes because their pre-existing double bonds complicate the normal β-oxidation cycle: Enoyl-CoA isomerase repositions double bonds from the cis configuration (naturally present in unsaturated fatty acids) to the trans configuration (produced by β-oxidation), allowing oxidation to continue 2-Methylacyl-CoA racemase handles situations where the double bond is positioned such that β-oxidation would produce a methyl-branched CoA derivative; this enzyme converts the CoA to the required isomer Without these enzymes, oxidation would stall at pre-existing double bonds, trapping energy in the fatty acid. Odd-Chain Fatty Acids Most fatty acids are even-chained because they are synthesized from two-carbon units. However, odd-chain fatty acids (primarily from ruminant dairy products and some marine sources) require special handling: The final cycle of β-oxidation yields one propionyl-CoA (three carbons) instead of acetyl-CoA Propionyl-CoA is converted through multiple steps (involving propionyl-CoA carboxylase and methylmalonyl-CoA mutase) into succinyl-CoA, which enters the citric acid cycle directly This provides a source of glucose synthesis (gluconeogenesis) from fatty acids, which is otherwise impossible from acetyl-CoA alone <extrainfo> Bacterial Fatty Acid Synthesis (Type II FAS) Contrast with Animal Synthesis In bacteria, fatty acid synthesis operates differently from animals. Instead of a large multifunctional enzyme complex (Type I FAS, found in animals), bacteria use Type II FAS: a series of discrete enzymes that each catalyze one step of elongation. These include: Fatty acid synthase (condensing enzyme) β-Ketoacyl-ACP reductase Dehydratase Enoyl-ACP reductase Acyl carrier protein (ACP) Regulatory Advantages The Type II system offers an evolutionary advantage: each enzyme can be independently regulated based on cellular conditions. This is particularly important in bacteria, which must rapidly adapt to changing nutrient availability. In contrast, the animal Type I complex is more difficult to regulate at individual steps, relying instead on allosteric control at the committed carboxylase step. Antibiotic Implications Because bacterial Type II FAS is distinct from animal biosynthesis, several antibiotics (such as triclosan and isoniazid) selectively inhibit bacterial fatty acid synthesis without significantly affecting human synthesis. This selectivity makes these compounds valuable therapeutics. </extrainfo> <extrainfo> Animal Fatty Acid Synthase Structure Animal fatty acid synthase is a massive homodimeric protein (two identical subunits, each 250 kDa) that contains multiple catalytic domains: Ketoacyl synthase domain: Catalyzes the condensation reaction Acyl carrier protein (ACP) domain: Carries growing fatty acid intermediates during synthesis Enoyl reductase domains: Catalyze both reduction steps The ACP domain acts like a "bucket brigade worker," transferring the growing chain from one catalytic site to the next in a processive manner. This organization allows the enzyme to rapidly cycle through the condensation, reduction, dehydration, and second reduction steps without releasing intermediates. The homodimeric structure is thought to enable transfer of intermediates between the two subunits, enhancing efficiency—though the precise molecular details remain an area of active research. </extrainfo>